Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Amylin Raises $175M Through Sale Of Senior Convertible Notes

April 2, 2004

By Aaron Lorenzo

CancerVax Follow-Up Results Show Canvaxin Survival Benefit

April 1, 2004

By Aaron Lorenzo

CancerVax Follow-Up Results Show Canvaxin Survival Benefit

April 1, 2004

By Aaron Lorenzo

Peregrine Presents Positive Preclinical Findings At AACR

March 31, 2004

By Aaron Lorenzo

Peregrine Presents Positive Preclinical Findings At AACR

March 31, 2004

By Aaron Lorenzo

OxiGene Shares Get A Boost From Preclinical Cancer Data

March 30, 2004

By Aaron Lorenzo

OxiGene Shares Get A Boost From Preclinical Cancer Data

March 30, 2004

By Aaron Lorenzo

Recently Formed By Merger, PainCeptor Nets C$23 Million

March 23, 2004

By Aaron Lorenzo

Recently Formed By Merger, PainCeptor Nets C$23 Million

March 23, 2004

By Aaron Lorenzo

Critical Therapeutics Files For Estimated $103.5M IPO

March 22, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...